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Abstract
Objectives Ambient particulate matter (PM) is regulated with science-based air quality standards, whereas carcinogens are
regulated with a number of ‘‘acceptable’’ cases. Given that PM is also carcinogenic, we identify differences between
approaches.
Methods We assessed the lung cancer deaths for Switzerland attributable to exposure to PM up to 10 lm (PM10) and to
five particle-bound carcinogens. For PM10, we used an epidemiological approach based on relative risks with four exposure
scenarios compared to two counterfactual concentrations. For carcinogens, we used a toxicological approach based on unit
risks with four exposure scenarios.
Results The lung cancer burden using concentrations from 2010 was 10–14 times larger for PM10 than for the five
carcinogens. However, the burden depends on the underlying exposure scenarios, counterfactual concentrations and
number of carcinogens. All scenarios of the toxicological approach for five carcinogens result in a lower burden than the
epidemiological approach for PM10.
Conclusions Air quality standards—promoted so far by the WHO Air Quality Guidelines—provide a more appealing
framework to guide health risk-oriented clean air policymaking than frameworks based on a number of ‘‘acceptable’’ cases.
Keywords Air pollution  Particulate matter  Lung cancer  Epidemiology  Toxicology  Health impact assessment 
Carcinogens
Introduction
Ambient air pollution causes around 4.2 million annual
deaths at the global level (Cohen et al. 2017). Clean air
policies have been adopted by public authorities worldwide
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to limit exposures, and thus to minimize adverse health
effects. In Switzerland, which is the focus of this study, the
Swiss Environmental Protection Act (EPA) is in force since
1985 (Swiss Federal Council 2018a). It provides the legal
framework for air pollution policy and entrusts the Federal
Council to stipulate limit values by specific ordinances,
like the Swiss Ordinance on Air Pollution Control (OAPC)
(Swiss Federal Council 2018b) (see Supplementary
Materials).
The regulation for ambient criteria of air pollutants such
as the mass of particulate matter (PM) or some gases dif-
fers from those adopted for single carcinogenic air
pollutants.
In the case of criteria pollutants, the World Health
Organization (WHO) uses the global scientific literature on
health effects to propose Air Quality Guidelines, which are
set at a level to protect public health (WHO-Europe
2000, 2006). Epidemiological studies play a fundamental
role in the assessment of the body of evidence, particularly
in the setting of guideline values to prevent long-term
health effects, as those are not amenable to experimental
research in humans. Henceforth, we call this the ‘‘epi-
demiological approach.’’ In Switzerland, the OAPC ambi-
ent air quality standards are to a large extent in accordance
with the WHO Air Quality Guidelines (WHO-Europe
2000, 2006; Swiss Federal Council 2018b).
In the case of carcinogenic air pollutants, policies
acknowledge the absence of identifiable ‘‘thresholds of no
effect.’’ Thus, given that nonzero exposures to carcinogens
result in nonzero health effects, the common policy goal is
to keep exposure ‘‘as low as possible’’ and express ambient
concentrations of carcinogens in terms of risk levels, i.e.,
the number of cancer cases ‘‘accepted’’ to be caused by
these pollutants. The following three risk levels are the
most commonly used worldwide: 1 in 1,000,000, 1 in
100,000 and 1 in 10,000, i.e., 1 per 1,000,000, 1 per
100,000 and 1 per 10,000 persons of exposed people are
expected to develop cancer due to lifetime exposure (usu-
ally defined as 70 years) to one carcinogen, respectively
(WHO-Europe 2000). Henceforth, we call this the ‘‘toxi-
cological approach’’ given that toxicology is often the
pillar of such risk assessments. In Switzerland, an assess-
ment commissioned by the Swiss Federal Office for the
Environment (FOEN) considered 1 in 1,000,000 to most
satisfactorily reflect the protection criteria as set in the
Swiss EPA (Brunner 2000).
For ambient PM, the dichotomy of this risk framework
is questioned twice.
First, PM is not only considered a criteria pollutant
(IARC-WHO 2016, p. 36) but, since 2013, also a car-
cinogen (IARC-WHO 2013). The International Agency for
Research on Cancer classified PM as Group 1 carcinogen
(the highest risk rank), which means that there is
‘‘sufficient evidence of carcinogenicity in humans.’’
Exposure to ambient PM has conclusively been shown to
be associated with lung cancer, while the association with
other types of cancer is less certain (Loomis et al. 2013).
Thus, PM is on the one side considered a complex mixture
and marker of ambient air pollution—traditionally regu-
lated with air quality standards or ‘‘limit values’’—and on
the other side it is a carcinogen, which is usually regulated
under the ‘‘as low as possible’’ risk-level paradigm. In the
first case, health impacts are typically derived from relative
risks or excess rates published in epidemiological studies
(WHO 2013) and are the basis of all estimates published by
the Global Burden of Disease (Lim et al. 2012; Cohen et al.
2017). In the second case, cancer cases attributable to
carcinogens are typically calculated based on their unit
risks, usually derived from toxicological studies (e.g.,
Morello-Frosch et al. 2000; Woodruff et al. 1998).
Second, epidemiology-based risk assessments of PM
now use various counterfactual concentrations. A range of
previous studies (e.g., Ro¨o¨sli et al. 2003; Ku¨nzli et al.
1997, 2000) used a counterfactual concentration of 7.5 lg/
m3 of PM smaller than 10 lm in aerodynamic diameter
(PM10), reflecting the mean value of the—at that time
lowest—exposure category ‘‘5–10 lg/m3.’’ Meanwhile,
many epidemiological studies include participants exposed
to very low outdoor concentrations of PM (Beelen et al.
2014), possibly as low as the concentrations measured at
alpine monitoring stations (e.g., 2.2 lg/m3 for PM10 at
Jungfraujoch in 2010). A recent study derived a novel
concentration–response function for the association
between long-term exposure to PM and mortality based on
results from 41 cohorts conducted in 16 countries (Burnett
et al. 2018). This risk function suggests the effects of PM
smaller than 2.5 lm in aerodynamic diameter (PM2.5) to be
observed down to an annual mean of 2.4 lg/m3. Assuming
that in Switzerland PM2.5 accounts for 73.5% of PM10
(BAFU 2019), this counterfactual value is equivalent to
3.3 lg/m3 of PM10.
To date, it is not clear whether air quality standards
provide equal protection of public health as the approach
based on a number of ‘‘acceptable’’ cases. Therefore, the
objective of our study was to estimate premature lung
cancer deaths attributable to air pollution with both the
epidemiological and the toxicological approaches and with
varying choices of exposure scenarios and counterfactual
concentrations for Switzerland. We focused on lung cancer
mortality for both approaches given the established link
with ambient PM as well as a range of single carcinogens.
For the epidemiological approach, we used PM10 as the
marker of ambient air pollution, due to the extensive
availability of PM10 data as compared to PM2.5 in
Switzerland. For the toxicological approach, we focused on
five carcinogens: arsenic, benzo[a]pyrene (as a marker of
A. Castro et al.
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polycyclic aromatic hydrocarbons), cadmium, elemental
carbon (or soot, taken as a marker of diesel exhaust) and
nickel. We restricted the assessment to inhalable particle-
bound carcinogens (excluding fibers) with available unit
risk factors from the literature and ambient concentration
data from the National Air Pollution Monitoring Network
(NABEL) (see Supplementary Materials).
Methods
Epidemiological approach
For the epidemiological approach, we estimated the num-
ber of premature lung cancer deaths, which are
attributable to PM10 exposure based on the excess rate
(Ro¨o¨sli et al. 2003) according to Eq. 1. To calculate excess
rates, we applied Eq. 2 (Ro¨o¨sli et al. 2003).
Equation 1: Estimation of the number of lung cancer
deaths by an epidemiological approach based on excess
rate.
DER ¼
Pop 30
100; 000
 PWCexp  PWCcf
   ER1  1  SRð Þ
ð1Þ
DER = number of lung cancer deaths that are attributable to
air pollution per year based on excess rate. PopC30 =
population aged 30 and older. PWCexp = annual popula-
tion-weighted PM10 mean concentration in lg/m
3 for an
exposure level. PWCcf = annual population-weighted
PM10 mean counterfactual concentration in lg/m
3.
ER1 = excess rate in a number of annual lung cancer cases
per 100,000 persons aged 30 and older, per 1 lg/m3
increase. SR = survival rate of lung cancer patients.
Equation 2: Calculation of the excess rate.
ER1 ¼ Iloc  ln RRgen;1
  ð2Þ
ER1 = excess rate in a number of lung cancer cases per
100,000 person-years and per 1 lg/m3 increase in con-
centration. Iloc = local observed lung cancer incidence in
cases per year per 100,000 persons. RRgen,1 = generic rel-
ative risk of incidence (with lower and upper bounds of the
95% confidence interval from the literature) per 1 lg/m3
increase.
We defined four PM10 exposure scenarios (20, 18, 13
and 11 lg/m3). The first one (20 lg/m3) assumes the
population-weighted annual mean concentration to corre-
spond to the OPAC air quality standard (Swiss Federal
Council 2018b), which is the same as the value of the
WHO air quality guideline. The second exposure scenario
(18 lg/m3) corresponds to the estimated population-
weighted mean for 2010 from ten NABEL stations as
derived by the FOEN and the Swiss Federal Laboratories
for Material Science and Technology (BAFU 2019). In the
third exposure scenario (13 lg/m3), we assumed that PM10
concentrations comply with the OPAC PM10 air quality
standard everywhere in Switzerland, including hot spots.
This is an estimate derived by FOEN and based on most
recent data and spatial models. In the fourth exposure
scenario (11 lg/m3), we assumed compliance of ambient
PM2.5 annual mean concentrations with the newly adopted
OPAC air quality standard of PM2.5—which corresponds to
the WHO guideline value of 10 lg/m3—throughout the
whole country. Assuming compliance with the limit value
at 99% of all residential sites, the population-weighted
mean concentration was 17% below the limit value,
namely 8.3 lg/m3 of PM2.5 (Ro¨o¨sli 2014). The mean value
assuming 100% compliance was not provided. Assuming
that 73.5% of PM2.5 accounts for PM10 (BAFU 2019),
8.3 lg/m3 of PM2.5 can be converted into approximately
11 lg/m3 of PM10.
The health burden of these exposure scenarios was
calculated against two counterfactual concentrations,
namely 7.5 lg/m3 as annual population-weighted mean
concentration of PM10 (Ku¨nzli et al. 2000; Ro¨o¨sli et al.
2003) to enable comparability with other health impact
assessments and 3.3 lg/m3 to consider the estimation of
the recently published risk function mentioned above
(Burnett et al. 2018).
Toxicological approach
For the toxicological approach, we estimated the number of
lung cancer deaths caused by carcinogenic air pollutants
applying Eq. 3 (Ro¨o¨sli et al. 2003). This equation does not
account for synergistic effects between carcinogens.
Equation 3: Estimation of the number of lung cancer
deaths using a toxicological approach based on unit risk.
DUR ¼
Xn
i¼1
Pop 30
100; 000
 PWCi;exp  PWCi;cf
   URi
LT
 1  SRð Þ ð3Þ
DUR = local number of lung cancer deaths per year that are
attributable to air pollution based on unit risk. i = car-
cinogen. n = number of carcinogens. PopC30 = population
aged 30 and older. PWCi,exp = annual population-weighted
mean concentration of the carcinogen i for an exposure
level. PWCi,cf = annual population-weighted mean coun-
terfactual concentration of the carcinogen i. URi = unit risk
in lifetime cases per 100,000 persons aged 30 and older for
exposure to 1 lg/m3 of the carcinogen i (from literature).
LT = lifetime in years. SR = survival rate of lung cancer
patients.
The population-weighted mean concentration data of the
five carcinogens are from 2010 and were provided by the
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FOEN (BAFU 2019). In this data set, the concentration of
elemental carbon was measured as a marker of diesel
exhaust at eight NABEL stations. The concentrations of the
other four carcinogens were measured at ten NABEL sta-
tions (the same eight stations as for elemental carbon plus
two additional ones).
When estimating the health burden, we summed the
lung cancer cases under the scenarios of the three risk
levels (1 in 10,000, 1 in 100,000 and 1 in 1,000,000) across
the five considered carcinogens. For instance, multiplying
the lifelong risk level of 1 in 1,000,000 by five carcinogens
and dividing by 70 years of assumed lifetime (1*5/70)
result in 0.07 deaths per 1,000,000 persons per year.
The counterfactual concentration assumes that the con-
centration of carcinogens is zero, since their emission is
mainly due to human activity (WHO-Europe 2000; Ro¨o¨sli
et al. 2003).
Values and references of other data used for the epi-
demiological and for the toxicological approach can be
found in Tables 1 and 2, respectively. Further information
on these data is provided in the Supplementary Materials.
Results
For the 2010 exposure scenario, the epidemiological
approach attributes 255 and 357 annual lung cancer deaths
to PM10 in Switzerland for the counterfactual concentra-
tions of 7.5 lg/m3 (scenario A2) and 3.3 lg/m3 (scenario
B2), respectively (Table 1). This health burden is 10–14
times higher when using the epidemiological approach than
when using the toxicological approach, which attributes 25
annual lung cancer deaths to the five carcinogens (scenario
C1) at levels from 2010 (Table 2). Elemental carbon
accounts for more than 90% of the burden of the five
carcinogens included in this study.
Table 1 highlights the differences in health burdens
when using different exposure scenarios and counterfactual
concentrations. When comparing scenario B1 with A1, the
choice of the lowest counterfactual concentration (3.3 lg/
m3) leads to a 34% larger burden than choosing the tradi-
tional counterfactual concentration of 7.5 lg/m3. When
comparing scenario B4 with A4, the more stringent coun-
terfactual value results in a 120% larger burden than the
one referring to the traditional counterfactual of 7.5 lg/m3.
Further reductions of ambient PM10 from the estimated
2010 population-weighted mean concentration of
18–13 lg/m3 will reduce the attributable lung cancer
deaths per year from 255 to 134 (scenario A2 vs. A3) or
from 357 to 236 (scenario B2 vs. B3). Furthermore,
Tables 1 and 2 show that all risk models of the toxico-
logical approach for five carcinogens (scenario C2, C3 and
C4) result in accepting much less annual lung cancer deaths
in Switzerland (from 0.4 to 40.5) than any of the epi-
demiological scenarios for PM10 (from 85 to 406).
Using the epidemiological approach, we calculated the
PM10 equivalent concentration increase, which would
correspond to the three risk levels (1 in 10,000, 1 in
100,000 and 1 in 1,000,000) and to the related toxicology-
based scenarios C2, C3 and C4 (5 in 10,000, 5 in 100,000
and 5 in 1,000,000, respectively) (see Supplementary
Materials). If one accepts 5 lifetime lung cancer deaths per
10,000, 100,000 and 1,000,000 persons (scenarios C2, C3,
C4), the population-weighted annual mean concentration of
PM10 can be only 1.7, 0.17 and 0.017 lg/m
3 above the
counterfactual point of reference, respectively. Thus, under
the most conservative risk model of 1 in 1,000,000, the
PM10 concentrations could be only 0.003 lg/m
3 above the
counterfactual value.
As shown in our sensitivity analyses (see Supplementary
Materials), all factors are similarly influential when
increasing their value in both epidemiological and toxico-
logical approaches.
Discussion
General findings and uncertainties
This study juxtaposes two risk assessment approaches
combining four concentration scenarios with two counter-
factual choices to put lung cancer deaths attributable to
ambient air pollution into the context of risk assessment
methods and concepts. In line with previous studies, we
found that the sum of the unit risk-based attributable deaths
across single carcinogens identifies only a fraction of the
total burden captured with the excess rate-based epidemi-
ological approach for PM10 (see Supplementary Materials).
To guarantee comparability with previous assessments, we
used PM10 instead of PM2.5 as the marker or air pollution
(e.g., Ro¨o¨sli et al. 2003). In line with those studies and the
Global Burden of Disease (Cohen et al. 2017), we used
attributable cases instead of years of life lost (He´roux et al.
2015, 2017; Morfeld and Erren 2017).
Our quantitative comparison of the toxicology-based
paradigm with the epidemiology-based assessment of
attributable deaths reveals interesting differences in the
(implicit) acceptance of risk underlying these two approa-
ches. As shown in Tables 1 and 2, none of the PM10 sce-
narios fully complies with tolerating any risk level for five
carcinogens.
The number of attributable deaths differs both in relative
and in absolute terms under a range of alternative
methodological assumptions to be discussed in more detail
below.
A. Castro et al.
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First, our two counterfactual PM10 concentrations (7.5
vs. 3.3 lg/m3) highlight the strong influence of this
parameter. Although it is appropriate to disclose
attributable deaths down to very low counterfactual levels,
it should be well communicated that the apparent increase
in the attributable burden is caused by the alternative
counterfactual value rather than by changes in the toxicity
of air pollution.
Second, the values we choose for the relative risk
determine the excess rate in the epidemiological approach.
Ideally, the relative risk estimate would originate from
Switzerland, but this is not available. We used the world-
wide PM2.5 relative risk estimate for lung cancer incidence
from the meta-analysis of Huang et al. (2017). We selected
this relative risk because it is (1) from the most recent
meta-analysis, (2) specific for incidence (not mixed with
mortality) and (3) based on a higher number of studies than
the European estimates. This choice results in a number of
deaths rather similar to the one estimated in a study com-
missioned by the Swiss Federal Office for Spatial Devel-
opment (ECOPLAN and INFRAS 2014). For public
authorities, methodological consistencies facilitate the
communication of results over time. However, one could
also argue for other choices from the identified nine rela-
tive risk estimates published in three international meta-
analyses (Raaschou-Nielsen et al. 2013; Hamra et al. 2014;
Huang et al. 2017). Depending on the choice of relative
risk, the attributable annual lung cancer deaths for the
scenario A2 (255 in our study) range from 98 to 1079 (see
Supplementary Materials). Smoking cannot explain this
heterogeneity in the relative risk estimates because the
studies used for the calculation of the relative risk estimate
adjusted for smoking (among other factors). Whereas
public authorities may prefer using the same relative risks
for all consecutive studies to better compare results and
trends, it is inevitable that new and possibly more appro-
priate risk estimates get published and, thus, used in risk
assessments. Therefore, there is a need for proper com-
munication strategies to explain the meaning of uncer-
tainties and ‘‘conflicting results,’’ which are driven by
methodological choices rather than by changes in the tox-
icity of air pollution.
Third, the choice of the lung cancer incidence impacts
the excess rate. We used average incidence data from the
period 2011–2015 rather than some theoretical ‘‘baseline
incidence’’ before exposure to ambient air pollution. The
latter is not available, but we conjecture this uncertainty to
be of minor influence given that lung cancer incidence is
most strongly driven by smoking, which tended to become
less prevalent over the past decades.
Fourth, the choice of unit risk factors determines the
result of the health assessment in the toxicological
approach. Most unit risks are based on occupational studies
(see Supplementary Materials). Transferability of the risk
estimates to the general population involves uncertainties.
On the one hand, this implies extrapolation of risk func-
tions with unknown errors from much higher occupational
exposures down to ambient air concentrations. On the other
hand, the higher proportion of vulnerable persons in the
general population or the higher toxicity of metals in acid
ambient aerosols (Nordberg et al. 1985) may result in the
underestimation of risks, if one relies on occupational
studies alone. Similarly, the combined interaction of mul-
tiple carcinogens or between carcinogens and other pollu-
tants is not captured in the occupational studies
(Kawaguchi et al. 2006; Berenbaum 1985); thus, the health
burden might be underestimated.
Fifth, the inclusion of additional carcinogens would
increase the number of attributed deaths. Furthermore,
some of the considered carcinogens are markers of larger
groups of substances. If we had included the effect of the
whole group, the resulting health burden would have been
higher (see Supplementary Materials). We conclude that
the restriction to five carcinogens explains part of the
strong difference between the PM10 and carcinogen-based
attributable deaths of lung cancer. PM10 captures not only
all particle-bound carcinogens but also various interactions
between these substances as well as, to some extent,
interactions with correlated exposures to gases.
Sixth, derived population-weighted mean concentrations
of PM10 and carcinogens might have some uncertainty,
because they are based on a limited number of monitoring
stations (up to ten in our study), but the stations are rep-
resentative for most populous areas. Alternatively, PM10
can rely on comprehensively validated hybrid maps using
spatial models, based on a range of monitoring stations,
emission data and spatial information. For 2010 (scenarios
A2, B2 and C1), the estimated concentration from the
model was only 3% higher than the one from the NABEL
stations used in our analyses; thus, our study is not sensi-
tive to this methodological choice. A further non-quan-
tifiable uncertainty relates to the selected year(s) to derive
the exposure. Lung cancer has a long latency period, i.e.,
the incidence is a result of ‘‘past long-term exposure.’’ We
used data from 2010; thus, the implicit assumption is that
these values also stand for the longer-term exposure.
However, the PM10 population-weighted concentration
decreased strongly between 1991 and 2015 from over 30 to
approximately 15 lg/m3. Similarly, concentrations of car-
cinogens were also reduced by varying proportions.
Although the size of these temporal uncertainties is
unknown, we expect all scenarios to be similarly affected;
thus, comparisons across approaches and scenarios remain
valid.
Seventh, we assumed that the survival rate of lung
cancer cases was zero. The 10-year survival rate of Swiss
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lung cancer patients between 1998 and 2012 was on
average 10% (11% for women and 9% for men) (Arndt
et al. 2016). If we applied a nonzero survival rate, one
would have obtained a proportionally lower number of
attributable deaths. However, survival data for periods
beyond 10 years—relevant for our risk assessment—are
not available. If lung cancer is ultimately considered non-
curable, our assumption may result in a negligible bias.
Policy implications
A major motivation of this study related to the question,
whether the current regulatory framework of PM, with its
science-based air quality standards, remains an adequate
choice despite PM now being accepted as a carcinogen. As
shown in our assessment, all risk models of the toxico-
logical approach for five carcinogens correspond to
accepting much less lung cancer deaths in Switzerland than
the ones attributed to PM10. However, although the
approach to define ‘‘acceptable’’ cases is apparently much
stricter, we see a range of advantages in maintaining air
quality standards versus replacing it with the risk-level
framework commonly used for single carcinogens.
First and foremost, PM10 is not only a carcinogen but
causes a range of non-cancer morbidities and related pre-
mature deaths such as cardiovascular and respiratory dis-
eases (WHO-Europe 2013). Furthermore, other types of
cancer beyond lung cancer have been associated with PM
exposure, e.g., sinonasal cancer (WHO-Europe 2000,
p. 202), oral cancer (Chu et al. 2018) and possibly breast
cancer (Andersen et al. 2017; White et al. 2018; Cheng
et al. 2019). Indeed, the list of identified health effects of
PM is constantly increasing. Under a policy framework of
‘‘acceptable’’ risk levels, e.g., 1 in 1,000,000, the ‘‘ac-
ceptable’’ target concentration would constantly change,
namely decrease, with every additional outcome consid-
ered to be causally related to PM. Such ‘‘moving targets’’
are not only difficult to communicate to policymakers and
the population at large, but also pose a major challenge for
the agencies in charge of clean air development plans. In
addition, ‘‘moving targets’’ jeopardize the proper commu-
nication of progress in clean air policy. Indeed, a policy
framework defining the number of ‘‘acceptable’’ cases
instead of setting ambient air quality standards, as used for
all criteria pollutants, would force policymakers to define
the number of ‘‘acceptable’’ cases for each air pollutant and
each of the many health outcomes to then derive the related
clean air target value (Thurston et al. 2017).
For carcinogens not regulated with limit values, we
rather recommend agencies to continue the ‘‘as low as
possible’’ policy. In line with this notion, the Swiss Federal
Commission for Air Hygiene (EKL in German) recom-
mended in 2013 to reduce airborne elemental carbon, as a
marker of diesel exhaust, to 20% of the levels observed at
that time, within 10 years (EKL 2013). Based on Table 2,
this recommendation approximately corresponds to
accepting around five deaths per year and it only complies
with a level of risk of 1 in 1,000,000.
As shown in our assessment, air quality standards for
PM provide a transparent base to estimate premature deaths
under a broad range of policy scenarios. We consider of
particular interest our scenario using 11 lg/m3 as a coun-
terfactual PM10 concentration to comply with the newly
adopted annual PM2.5 limit value. PM10 concentrations are
substantially determined by the PM2.5 values, and over the
past decades, clean air policies reduced ambient concen-
trations of both particle fractions in parallel. However, the
OPAC annual air quality standards of PM2.5 (10 lg/m
3) are
de facto more stringent than the related PM10 target (20 lg/
m3). Indeed, whereas all Swiss monitoring sites comply
with the latter, PM2.5 concentrations remain above the limit
values at several sites. Once PM2.5 values comply at all
sites, including hot spots, the population-weighted mean
PM2.5 is expected to be close to 8.3 lg/m
3 and PM10
concentrations approximately at 11 lg/m3, assuming that
73.5% of PM10 consist of PM2.5 (BAFU 2019).
Our findings may also guide the upcoming revision of
the WHO Air Quality Guidelines (WHO-Europe 2016),
where the lack of an apparent PM threshold of no adverse
effect and its definition as a carcinogen cannot be ignored
either. According to the above arguments, we consider the
promotion of fixed air quality guideline values appealing
and appropriate. A major challenge of the WHO Air
Quality Guideline does not relate to the science-based
derivation of such limit values, but to globally convince
governments to adopt these values in national regulations,
to enforce clean air strategies (Kutlar Joss et al. 2017), to
communicate health benefits of clean air policies (Henschel
et al. 2012) and to provide guidance in the interpretation of
the burden of ambient air pollution given its mixture of
many pollutants (He´roux et al. 2015).
Conclusions
Our comparison of the epidemiological and toxicological
approach to assess the lung cancer burden in the whole
population has shown that the epidemiological approach
using a marker of air pollutants, e.g., PM, can better cover
the exposure of the whole population than a limited
selection of single carcinogenic air pollutants. Thus,
applying a toxicological approach for only five inhalable
particle-bound carcinogens with a risk level of 1 in
1,000,000, 1 in 100,000 and 1 in 10,000 for each car-
cinogen resulted in a number of lung cancer deaths that is
smaller than the more comprehensive epidemiology-based
derivation for PM10. Whereas single carcinogens may be
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regulated under an ‘‘acceptable’’ number of cases risk
framework, our study emphasizes the advantage of air
quality limit values to regulate complex mixtures of par-
ticulates or particle-bound pollutants such as PM, irre-
spective of their carcinogenicity or the absence of
thresholds of no effect. Setting science-based ambient
standards at a fixed level as promoted by the WHO Air
Quality Guidelines remains a pragmatic, transparent and
efficient tool to guide effects-oriented clean air policy-
making and to monitor its success.
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